Skip to content
ppharmaranks
Menu

Direct Thrombin Inhibitor drugs compared

Compare all 1 Direct Thrombin Inhibitor drug side by side, used for conditions such as pulmonary embolism, venous thrombosis. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.

Full ranking · 1 drugs

  1. 1

    pradaxa

    Dabigatran Etexilate Mesylate

    72/100

Frequently asked questions

What is the Direct Thrombin Inhibitor drug class?

Direct Thrombin Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 1 Direct Thrombin Inhibitor product, each independently rated.

Are all Direct Thrombin Inhibitor drugs the same?

No. Direct Thrombin Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Direct Thrombin Inhibitor drugs treat?

Per NIH RxClass drug-classification data, Direct Thrombin Inhibitor drugs are used for conditions including pulmonary embolism, venous thrombosis.

Sources: the Direct Thrombin Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.